Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

China flag China · Delayed Price · Currency is CNY
14.33
+0.34 (2.43%)
Apr 29, 2026, 3:00 PM CST
1.27%
Market Cap 7.99B
Revenue (ttm) 1.81B
Net Income (ttm) 23.34M
Shares Out 571.39M
EPS (ttm) 0.04
PE Ratio 342.48
Forward PE 22.84
Dividend 0.21 (1.51%)
Ex-Dividend Date Jun 27, 2025
Volume 5,246,592
Average Volume 4,719,293
Open 14.18
Previous Close 13.99
Day's Range 14.06 - 14.44
52-Week Range 13.51 - 17.00
Beta 0.40
RSI 47.68
Earnings Date Apr 29, 2026

About Shenzhen YHLO Biotech

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers chemiluminescence immunoassay analyzer, diabetes solution, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2008
Employees 1,678
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688575
Full Company Profile

Financial Performance

In 2025, Shenzhen YHLO Biotech's revenue was 1.81 billion, a decrease of -9.99% compared to the previous year's 2.01 billion. Earnings were 23.34 million, a decrease of -92.26%.

Financial Statements

News

There is no news available yet.